Dr. Uzel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8136 Old Keene Mill Rd
Ste A309
Springfield, VA 22152Phone+1 800-287-2829Fax+1 703-726-2579- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1997 - 1999
- Sinai Hospital of BaltimoreResidency, Pediatrics, 1994 - 1997
- Ankara University FOMClass of 1991
Certifications & Licensure
- MD State Medical License 2002 - 2025
- VA State Medical License 2007 - 2022
- IL State Medical License 2002 - 2008
Clinical Trials
- Genetic Analysis of Immune Disorders Start of enrollment: 1995 Jun 06
- Antibody Production in Immune Disorders Start of enrollment: 2002 Jun 13
- Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsufficiency Start of enrollment: 2023 Nov 30
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Long-Term Treatment With Selective PI3Kδ Inhibitor Leniolisib in Adults With Activated PI3Kδ Syndrome.V Koneti Rao, Elaine M Kulm, Jennifer K Grossman, David K Buchbinder, Jason Bradt, Sharon Webster, Anna Šedivá, Virgil A Dalm, Hey Chong, Gulbu Uzel> ;Blood Advances. 2024 Apr 9
- Author Correction: GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.Ann Y Park, Michael Leney-Greene, Matthew Lynberg, Justin Q Gabrielski, Xijin Xu, Benjamin Schwarz, Lixin Zheng, Arasu Balasubramaniyam, Hyoungjun Ham, Brittany Chao, ...> ;Nature Immunology. 2024 Apr 1
- Hypogammaglobulinemia and immune dysregulation-not just 2 sides of a coin.Gulbu Uzel, Baerbel Keller, Klaus Warnatz> ;The Journal of Allergy and Clinical Immunology. 2024 Jan 1
- Join now to see all
Other
- Mendelian susceptibility to mycobacterial diseases (MSMD)Uzel G
http://www.uptodate.com/contents/mendelian-susceptibility-to-mycobacterial-diseases-msmd
UpToDate, Wolters Kluwer Health - 2012-09-19
Press Mentions
- Pharming Group Announces Development Plans for Leniolisib for Additional Primary Immunodeficiencies (PIDs)December 17th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: